Dr. Kamphaus has the dual role of leading FNIH Patient Engagement efforts and providing oversight to the Metabolic Disorders Programs within Translational Sciences. In her role as FNIH’s Patient Engagement lead, Dr. Kamphaus is responsible for establishing best practices for engaging patient voices for meaningful, end-to-end patient involvement in public-private partnerships within FNIH programs. She co-chairs to FNIH Patient Engagement Council, serves on the core committee for FNIH DEIA efforts, and is leading the establishment of a Patient Ambassadors Program. In her role as the Associate Vice President, Science Partnerships, she is responsible for developing new multi-stakeholder public-private partnerships that include stakeholders at NIH, FDA, non-profits and biopharmaceutical industry. Dr. Kamphaus oversees three target validation programs within